Efficacy RENO Study Results of Oral Vinorelbine or Etoposide with Cisplatin Et Chemo-Radiation in Stage III NSCLC. SLCG 10/02

被引：0

作者：

Isla, Dolores ^{[1
]}

De las Penas, Ramon ^{[2
]}

Marse, Raquel ^{[3
]}

Insa Molla, Amelia ^{[4
]}

Martinez-Banaclocha, Natividad ^{[5
]}

Moran, Teresa ^{[6
]}

Mut, Pilar ^{[7
]}

Angeles Sala, Maria ^{[8
]}

Massuti, Bartomeu ^{[9
]}

Ortega Granados, Ana Laura ^{[10
]}

Miguel Jurado, Jose ^{[11
]}

Artal Cortes, Miguel ^{[12
]}

Vazquez, Maria ^{[13
]}

Gutierrez, Vanesa ^{[14
]}

Diz Tain, Pilar ^{[15
]}

Gomez-Codina, Jose ^{[16
,17
]}

Maestu Maiques, Inma ^{[18
]}

Camps, Carlos ^{[19
]}

Vinolas Segarra, Nuria ^{[20
]}

Ponce Aix, Santiago ^{[21
]}

De Mon Soto, Melchor Alvarez ^{[22
]}

Garcia Gomez, Ramon ^{[23
]}

Provencio, Mariano ^{[24
]}

机构：

[1] Univ Hosp Clin Lozano Blesa, Med Oncol, Zaragoza, Spain

[2] Prov Hosp Castellon, Med Oncol, Castellon de La Plana, Spain

[3] Univ Hosp Son Espases, Med Oncol, Palma de Mallorca, Spain

[4] Univ Hosp Clin Valencia, Med Oncol, Valencia, Spain

[5] Gen Univ Hosp Elche, Med Oncol, Elche, Spain

[6] Hosp Badalona Germans Trias & Pujol, Med Oncol, Badalona, Spain

[7] Hosp Son Llatzer, Med Oncol, Palma de Mallorca, Spain

[8] Univ Hosp Basurto, Med Oncol, Bilbao, Spain

[9] Alicante Univ Hosp, Med Oncol, Alicante, Spain

[10] Complejo Hosp Jaen, Med Oncol, Jaen, Spain

[11] Univ Hosp San Cecilio, Med Oncol, Granada, Spain

[12] Univ Hosp Miguel Servet, Med Oncol, Zaragoza, Spain

[13] Univ Hospitality Complex Santiago, Med Oncol, Santiago De Compostela, Spain

[14] Reg Univ Hosp Malaga, Med Oncol, Malaga, Spain

[15] Assistent Complex Leon, Med Oncol, Leon, Spain

[16] Univ Valencia, Med Oncol, Valencia, Spain

[17] Polythecn Hosp La Fe, Valencia, Spain

[18] Univ Hosp Doctor Peset, Med Oncol, Valencia, Spain

[19] Gen Univ Valencia, Consorcio Hosp, Med Oncol, Valencia, Spain

[20] Univ Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[21] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain

[22] Univ Hosp Principe Asturias, Med Oncol, Alcala De Henares, Spain

[23] Univ Hosp Gregorio Maranon, Madrid, Spain

[24] Univ Hosp Puerta de Hierro, Med Oncol, Majadahonda, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

Locally advanced NSCLC; Oral Vinorelbine; chemotherapy; Radiotherapy;

D O I：

10.1016/j.jtho.2016.11.421

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA06.09

引用

页码：S373 / S374

页数：2

共 43 条

[21] GILT phase III study: Concomitant radiotherapy (RT) with Oral Vinorelbine (NVBo) plus Cisplatin (P) followed by consolidation (C) with NVBo+P plus BSC or BSC alone in stage (st) III NSCLC
Huber, R. M.
Engel-Riedel, W.
Kollmeier, J.
Andreas, S.
Staar, S.
Klautke, G.
Fietkau, R.
Vaissiere, N.
Osowski, S.
Flentje, M.
ONKOLOGIE, 2012, 35 : 167 - 168
[22] Induction (ICT) or consolidation chemotherapy (CT) with cisplatin (C) and paclitaxel (P) plus concurrent chemo-radiation (CT/TRT) with cisplatin and vinorelbine (V) for unresectable non-small cell lung cancer (NSCLC) patients (pts):: Randomized phase II trial GFPC-GLOT-IFCT 02-01.
Fournel, P.
Vergnenegre, A.
Robinet, G.
Lena, H.
Gervais, R.
Le Caer, H.
Souquet, P. J.
Chavaillon, J. M.
Chouaid, C.
Martel-Lafay, I.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 376S - 376S
[23] Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer
Chen, LM
Ignacio, L
Jacobs, R
Kozloff, M
Telfer, M
Elahi, R
Evans, R
Vijayakumar, S
RADIATION ONCOLOGY INVESTIGATIONS, 1999, 7 (01): : 49 - 53
[24] Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study
Herbach, Emma
O'Rorke, Michael A.
Carnahan, Ryan M.
McDowell, Bradley D.
Allen, Bryan
Grumbach, Isabella
London, Barry
Smith, Brian J.
Spitz, Douglas R.
Seaman, Aaron
Chrischilles, Elizabeth A.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (23):
[25] Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non-small cell lung cancer: Results of a single-arm prospective cohort study
Hsu, Ping-Chih
Chang, John Wen-Chang
Wang, Chun-Chieh
Wu, Chen-Te
Lin, Yu-Ching
Wang, Chih-Liang
Lin, Tin-Yu
Li, Shih-Hong
Wu, Yi-Chen
Kuo, Scott Chih-Hsi
Yang, Cheng-Ta
Liu, Chien-Ying
Chen, Chih-Hung
THORACIC CANCER, 2019, 10 (08) : 1683 - 1691
[26] Oral vinorelbine (NVBo) at 3-weekly flat-dose intakes (FDI) as single agent or with cisplatin (CDDP) concomitantly with thoracic radiotherapy (RT) in stage III NSCLC: Escalationdose phase I trial results
Kowalski, D. M.
Krzakowski, M. J.
Zajda, K.
Lucas, C.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[27] Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC):: Results of a prospective randomized study
Esteban, Emilio
de Sande, Jose-Luis
Villanueva, Noemi
Corral, Norberto
Muniz, Isabel
Vieitez, Jose Ma
Fra, Joaquin
Fernandez, Yolanda
Estrada, Enrique
Fernandez, Jose-Luis
Luque, Maria
Jimenez, Paula
Mareque, Beatriz
Capellan, Marta
Buesa, Jose Ma
Lacave, Angel Jimenez
LUNG CANCER, 2007, 55 (02) : 173 - 180
[28] Can combined chemo-radiation be started after induction chemotherapy in the curative treatment of stage III non-small cell lung carcinoma (NSCLC)? A multicenter, phase II study 5-year update
Faria, S.
Owen, S. P.
Soulieres, D.
Del Vecchio, P.
Ofiara, L.
Ayoub, J. M.
Charpentier, D.
Gruber, J.
Wan, J. F.
Souhami, L.
Kopek, N.
Hirsh, V.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[29] Preliminar analysis of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): NORA trial (GECP 15/02)
Majem Tarruella, M.
Isla Casado, L.
Guirado, M.
Massuti Sureda, B.
Ortega Granados, A. L.
Marse Fabregat, R.
Domine Gomez, M.
de las Penas, R.
Moran Bueno, M. T.
Vazquez Estevez, S.
Sala Gonzalez, M. A.
Coves Sarto, J.
Sanchez-Torres, J. M.
Vicente Baz, D.
Gonzalez-Larriba, J.
Paredes, A.
Farre, N.
Fernandez Fornos, L.
Mena, A.
Provencio Pulla, M.
ANNALS OF ONCOLOGY, 2017, 28
[30] RANDOMIZED STUDY TO ASSESS SAFETY & EFFICACY OF H-R3 MONOCLONAL ANTIBODY AGAINST EGF RECEPTOR IN COMBINATION WITH CHEMO-RADIATION THERAPY ADVANCED (STAGE III OR IVA) HEAD AND NECK CANCER
Viswanath, L.
Thimmaiah, L.
Bayyagari, K.
Shenoy, K.
Ashok, S.
Govinda, B.
Bindu, J.
Ravi, B.
ANNALS OF ONCOLOGY, 2009, 20 : 45 - 45

← 1 2 3 4 5 →